D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 22,777 307 World Ranking 9699 National Ranking 5131

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

David G. Beer mainly investigates Adenocarcinoma, Cancer research, Lung cancer, Pathology and Cancer. His research in Adenocarcinoma intersects with topics in Immunohistochemistry, Gene expression, Gene expression profiling, Molecular biology and Esophagus. The study incorporates disciplines such as Oncogene, Esophageal disease, CDKN2A, Gene duplication and Barrett's esophagus in addition to Cancer research.

His Lung cancer research is multidisciplinary, incorporating elements of Metastasis, Carcinoma and Lung. David G. Beer works mostly in the field of Pathology, limiting it down to concerns involving Respiratory disease and, occasionally, Candidate gene and Lymphocyte. His Cancer research includes themes of Notch signaling pathway, Immunology and Ectopic expression.

His most cited work include:

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
  • Comprehensive genomic characterization of squamous cell lung cancers (2590 citations)
  • Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung (354 citations)

What are the main themes of his work throughout his whole career to date?

David G. Beer mostly deals with Cancer research, Adenocarcinoma, Lung cancer, Internal medicine and Cancer. As a member of one scientific family, he mostly works in the field of Cancer research, focusing on Cell culture and, on occasion, Apoptosis. His work carried out in the field of Adenocarcinoma brings together such families of science as Immunohistochemistry, Pathology, Molecular biology, Lung and Esophagus.

His Molecular biology research incorporates themes from Gene duplication, Cell, Messenger RNA and Small interfering RNA. His Lung cancer research is multidisciplinary, relying on both Gene expression, Gene expression profiling, Bioinformatics, Stage and Tumor progression. His study on Internal medicine also encompasses disciplines like

  • Oncology and related Cohort,
  • microRNA, which have a strong connection to Real-time polymerase chain reaction.

He most often published in these fields:

  • Cancer research (46.73%)
  • Adenocarcinoma (37.58%)
  • Lung cancer (31.70%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (46.73%)
  • Lung cancer (31.70%)
  • Internal medicine (24.18%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Lung cancer, Internal medicine, Oncology and Cancer. His Cancer research research integrates issues from Cell growth, Apoptosis, Cell cycle, Immune system and microRNA. He interconnects Clinical trial, Metastasis, Lung and Adenocarcinoma in the investigation of issues within Lung cancer.

His work on Colon adenocarcinoma as part of general Adenocarcinoma research is often related to Characterization, thus linking different fields of science. He combines subjects such as Stage, Surgery, Gene, Hazard ratio and Cohort with his study of Oncology. His studies deal with areas such as MEG3, Dysplasia and Gene regulatory network as well as Cancer.

Between 2015 and 2021, his most popular works were:

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
  • The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (260 citations)
  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060)) (147 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

The scientist’s investigation covers issues in Lung cancer, Cancer research, Cancer, Adenocarcinoma and Oncology. The Lung cancer study combines topics in areas such as Stage, Metastasis and Lung. His Metastasis research incorporates elements of Stage classification and Pathology.

His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, Immune system, Immunotherapy, Chromatin and microRNA. His Cancer research focuses on subjects like Long non-coding RNA, which are linked to Cell, Cell biology, MRNA stabilization, Zebrafish and Ectopic expression. Adenocarcinoma is closely attributed to Survival rate in his work.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3641 Citations

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet.
Nature (2012)

3014 Citations

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

William D. Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G. Nicholson.
Proceedings of the American Thoracic Society (2011)

601 Citations

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)

562 Citations

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

William D. Travis;Hisao Asamura;Alexander A. Bankier;Mary Beth Beasley.
Journal of Thoracic Oncology (2016)

530 Citations

Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung

Mitch Raponi;Yi Zhang;Jack Yu;Guoan Chen.
Cancer Research (2006)

491 Citations

Proteomic Analysis of Lung Adenocarcinoma: Identification of a Highly Expressed Set of Proteins in Tumors

Guoan Chen;Tarek G. Gharib;Chiang Ching Huang;Dafydd G. Thomas.
Clinical Cancer Research (2002)

466 Citations

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

Kazuyuki Kawakami;Jan Brabender;Reginald V. Lord;Susan Groshen.
Journal of the National Cancer Institute (2000)

438 Citations

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.

Franck M. Brichory;David E. Misek;Anne Marie Yim;Melissa C. Krause.
Proceedings of the National Academy of Sciences of the United States of America (2001)

427 Citations

Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta.
Cell (2018)

350 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David G. Beer

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 123

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 92

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 91

Gad Getz

Gad Getz

Broad Institute

Publications: 84

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 68

Rameen Beroukhim

Rameen Beroukhim

Harvard University

Publications: 61

John D. Minna

John D. Minna

The University of Texas Southwestern Medical Center

Publications: 60

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 55

Andrew D. Cherniack

Andrew D. Cherniack

Broad Institute

Publications: 53

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 51

Manel Esteller

Manel Esteller

Institució Catalana de Recerca i Estudis Avançats

Publications: 45

Arul M. Chinnaiyan

Arul M. Chinnaiyan

University of Michigan–Ann Arbor

Publications: 44

Kwok-Kin Wong

Kwok-Kin Wong

New York University

Publications: 44

David C. Christiani

David C. Christiani

Harvard University

Publications: 44

Charles M. Rudin

Charles M. Rudin

Memorial Sloan Kettering Cancer Center

Publications: 43

Jing Wang

Jing Wang

The University of Texas MD Anderson Cancer Center

Publications: 42

Trending Scientists

James J. Little

James J. Little

University of British Columbia

Perinkulam S. Krishnaprasad

Perinkulam S. Krishnaprasad

University of Maryland, College Park

John E. Renaud

John E. Renaud

University of Notre Dame

Tianzhen Hong

Tianzhen Hong

Lawrence Berkeley National Laboratory

Stefan Becker

Stefan Becker

Max Planck Society

Kohei Uosaki

Kohei Uosaki

National Institute for Materials Science

Francesco Priolo

Francesco Priolo

University of Catania

Christine Klein

Christine Klein

University of Lübeck

Toren Finkel

Toren Finkel

University of Pittsburgh

Linda K. Ayliffe

Linda K. Ayliffe

Australian National University

Clive D. Rodgers

Clive D. Rodgers

University of Oxford

Roberto Caraballo

Roberto Caraballo

Garrahan Hospital

Christophe Grova

Christophe Grova

Concordia University

Sylvie Chokron

Sylvie Chokron

Université Paris Cité

T. Alp Ikizler

T. Alp Ikizler

Vanderbilt University Medical Center

Thomas Rauscher

Thomas Rauscher

University of Basel

Something went wrong. Please try again later.